Johnson & Johnson has secured an expanded indication from FDA for its TRUFILL n‑BCA Liquid Embolic System for embolization of the middle meningeal artery for the treatment of symptomatic subacute and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback